因地制宜发展新质生产力。天开高教科创园孵化的3900余家企业、近2倍增长的全国重点实验室、持续 领先的研发投入强度，这些创新要素的集聚，最终都转化为百姓身边的实在变化。从实验室的技术突破 到生活中的民生改善，天津的新质生产力发展始终锚定"人民对美好生活的向往"这一目标。在天津，高 水平研究型大学、科技领军企业等在科技创新不断取得"从0到1"的突破。 从百年工业积淀中汲取智慧，于新时代科创浪潮中勇立潮头，秉持"勇争先、善作为"的精神指引，天津 发展新质生产力的实践渐入佳境，努力为中国式现代化谱写新的篇章。 以科技创新引领产业创新，积极培育和发展新质生产力。南开大学科研团队瞄准新能源存储的核心难 题，通过材料与技术革新，研发的钙钛矿太阳能电池既解决了传统电池续航短、成本高的痛点，又攻克 了高温环境下的稳定性难题。天津大学神经工程团队锚定非侵入式脑机接口方向，10余年持续技术攻 关，用科技创新破解医疗难题。高校的科研体系，是促进科技创新和产业创新融合的关键一环。依托高 校作为科技创新的策源地和产业创新的推动者，天津正在着力构建人才培养、科技创新、成果转化三足 鼎立协同发展体系。 科技成果本身不是现实生产力，只有及时 ...

试着想象一幅画面：人类给大脑接入一个物理通道，通过意念就能与外界产生交互——几年前，这似乎 还是科幻电影中的场景，如今，这项技术——脑机接口正从实验室快步走向应用场景，并逐步建立起大 脑与数字世界之间的桥梁。 在10月24日中共中央新闻发布会上，国家发展改革委主任郑栅洁介绍和解读党的二十届四中全会精神 时，专门提到前文所述的脑机接口等六大产业，"这些产业蓄势发力，未来10年将再造一个中国高技术 产业。" 作为生命科学与信息技术交叉的前沿领域，脑机接口如何打破"脑"与"机"的壁垒，在医疗康复、产业应 用中实现从0到1的突破？在政策赋能、技术迭代与资本加持下，这项曾停留在科幻作品中的技术，正面 临哪些待解的难题，又将如何勾勒未来产业蓝图？记者采访了多位行业专家、产业从业者及科研人员， 解码脑机接口从实验室走向现实的进阶之路。 多地争抢脑机接口产业新高地 脑机接口技术，是指在人或动物大脑与外部设备之间创建直接连接，实现脑与设备的信息交换。作为一 种变革性的人机交互技术，其作用机制是绕过外周神经和肌肉，通过捕捉大脑信号并将其转换为电信 号，从而实现信息的传输和控制。 从形式来看，脑机接口主要分为侵入式、半侵入式和非侵 ...

Core Viewpoint - The article highlights the significant role of insurance capital in supporting technological innovation and the development of the "Six Little Dragons" in Hangzhou, showcasing a shift from traditional investment to a more integrated approach that combines capital with services [1][5][9]. Group 1: Investment Landscape - The "Six Little Dragons" of Hangzhou include several innovative tech companies that have attracted attention from capital markets, with plans for some to go public [2][3]. - Major insurance companies like China Life and Pacific Insurance are using indirect investment methods, becoming financial backers through a multi-layered investment structure involving private equity funds [2][3]. - Insurance capital has invested over 600 billion yuan in technology enterprises, reflecting a growing commitment to supporting the entire lifecycle of tech companies [5][6]. Group 2: Investment Models - Insurance funds primarily participate as limited partners in private equity funds, often collaborating with government or state-owned funds to invest in technology firms [4][5]. - The investment approach of insurance capital has evolved to include a mix of indirect equity investments and direct funding, aiming to balance safety and strategic value [4][8]. - The establishment of funds like the National SME Development Fund illustrates how insurance capital is leveraging government-led initiatives to invest in technology [3][4]. Group 3: Challenges and Solutions - Insurance capital faces challenges in aligning its traditional investment strategies with the high-risk, high-reward nature of technology innovation [7][8]. - To address these challenges, insurance asset management companies are innovating their investment models, such as using S-funds to better match long-term insurance capital with the needs of tech innovation [7][8]. - The shift towards a more proactive role as "active capital" reflects a broader trend of insurance funds becoming integral partners in the technology sector, moving beyond mere financial investors [9].

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth, driven by recent policy support and technological advancements, with several companies in the field seeing substantial stock price increases. Group 1: Company Performance - QiSheng Technology (麒盛科技) saw its stock price rise by 10.01% to 14.40, with a market capitalization of 5.08 billion, focusing on sleep-related technologies and brain-machine interaction [2] - Innovation Medical (创新医疗) increased by 9.99% to 20.59, with a market cap of 8.57 billion, holding a 40% stake in BoLing Brain-Machine Technology, which is developing core BCI technologies [2] - Xiangyu Medical (翔宇医疗) surged by 13.72% to 65.97, with a market cap of 10.56 billion, having completed several key projects in the BCI field and holding numerous patents [2] - Chengpin Technology (诚品通) rose by 8.60% to 23.23, with a market cap of 6.04 billion, collaborating with Tsinghua University on both non-invasive and invasive BCI technologies [2] Group 2: Industry Developments - On August 7, the Ministry of Industry and Information Technology and six other departments released guidelines to promote BCI innovation, aiming for breakthroughs in key technologies by 2027 [3] - The establishment of the Hubei BCI Industry Innovation Development Alliance was announced on August 9, indicating a collaborative effort to advance the sector [3] - The 2025 World Robot Competition showcased non-invasive BCI products for nerve injury treatment, highlighting the practical applications of BCI technology [3] Group 3: Institutional Insights - The guidelines emphasize the establishment of an advanced technology, industry, and standard system for BCI by 2027, with expectations for BCI applications in healthcare, rehabilitation, and skill replacement [4] - BCI technology is positioned at the intersection of life sciences and information sciences, facilitating collaboration between biological and machine intelligence [4] - Various provinces and cities in China are implementing policies to support BCI development, with significant potential for commercialization in healthcare and other sectors [5]

Core Insights - The article discusses a groundbreaking intervention using a brain-machine interface (BMI) to assist patients with motor function recovery after a stroke, allowing them to control their movements through thought alone [1][10]. Group 1: Technology Overview - Brain-machine interfaces connect the brain directly to external devices, bypassing peripheral nerves and muscles, which has been a focus of research for years [2]. - The intervention described is the first of its kind to use an invasive BMI for motor function rehabilitation, developed by a team led by Professor Duan Feng from Nankai University [1][4]. - The invasive BMI is implanted in the blood vessels surrounding the motor cortex, improving signal accuracy compared to non-invasive methods while avoiding the risks associated with traditional invasive procedures [4][5]. Group 2: Clinical Trials and Results - The team conducted successful animal trials before moving to human clinical trials, demonstrating the safety and efficacy of the invasive BMI [5][6]. - The first human trial involved a 67-year-old stroke patient who was able to perform tasks like grasping and manipulating objects with the assistance of the BMI [10]. - The BMI was implanted for several days without complications, and the patient showed improved control over their movements, indicating the potential for significant rehabilitation outcomes [10]. Group 3: Future Implications - The research aims to provide new treatment options for various motor function disorders, including stroke sequelae, spinal cord injuries, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) [10]. - The increasing prevalence of stroke in China highlights the urgent need for innovative rehabilitation technologies like the BMI [10]. - Several hospitals across the country are beginning to establish clinical research units for BMIs, indicating a growing interest and investment in this technology [10].